Keyword: Johnson & Johnson
News
26.08.2015
- Pfizer can now progress its $17 billion purchase of Hospira after receiving final regulatory approvals from the USA and Brazil. The clearance from the US Federal Trade Commission...
News
13.08.2015
- Irish drugmaker Mallinckrodt said it plans to acquire US immunotherapy company Therakos for $1.33 billion from American private equity investor Gores Group. The deal is planned to...
Strategy & Management
28.07.2015
- Almost every day, there are news stories about environmental damage and social inequality. Whether it is illegal immigrants attempting to enter Europe, erratic weather conditions...
News
28.06.2015
- Janssen Pharmaceuticals, subsidiary of Johnson & Johnson, has donated $6 million to Rutgers University in the US to fund ongoing research into continuous manufacturing – an...
News
08.06.2015
- An unusual lawsuit claiming the Food and Drug Administration (FDA) overstepped its bounds by deciding that two generic drugs used to treat attention deficit hyperactivity disorder...
News
28.05.2015
- AbbVie has completed the acquisition of Pharmacyclics, a deal the Chicago-based US drugmaker says enhances its scientific and commercial presence in oncology. As a wholly owned...
News
21.05.2015
- Johnson & Johnson's Janssen Pharmaceuticals offshoot has told analysts it plans to seek regulatory approval for more than 10 new drugs up to 2019, each with the potential to...
News
20.05.2015
- US pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over the marketing of its antipsychotic drug Risperdal to doctors in the US state of...
